ClinicalTrials.Veeva

Menu

Mechanisms and Modulation of Pain Modulatory Capacity

University of Florida logo

University of Florida

Status

Enrolling

Conditions

Musculoskeletal Pain

Treatments

Behavioral: Delayed onset muscle soreness.

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04441619
R01AR073745-01A1 (U.S. NIH Grant/Contract)
IRB20190295 3-N

Details and patient eligibility

About

This project proposes to understand the sources of pain variability, and demonstrate that pain variability represents fluctuation in natural pain management. The project further proposes to determine if endogenous capacity to modulate pain can be trained to maximize their body's ability to manage pain, much as the way in which athletic performance can be trained.

Full description

Many physiological systems (bioenergy, immune etc.) involve feedback mechanisms to respond to challenges, with increased output or capacity for adaptive change. A similar process is plausible for pain modulation where previous successful pain experience and resolution suggests a pain modulatory system with adaptive capacity. The proposed research examines how a musculoskeletal training program modulates pain response in people with fibromyalgia compared to healthy individuals. Previous research suggests that moderate-high level exercise is associated with attenuation of pain sensitivity and clinical pain intensity in healthy individuals. The proposal seeks to extend findings from previous research and examine how repeated exposure and subsequent adaptations to musculoskeletal pain over time influence pain modulation (PMC). The first outcome is that people with fibromyalgia (FM) will have PMC trainability similar to asymptomatic controls, with the obvious implications for clinical application. The second outcome is that FM patients will demonstrate a deficit in PMC trainability. This outcome will represent an important diagnostic sign, and guide research to additional mechanistic investigation. The third outcome is that impaired or lessened PMC trainability is evident in FM patients and this variability can be explored as an individual difference with clinical implications. The theoretical fourth potential outcome is sensitization in FM patients, however pilot data show that DOMS resolves within the same relative time window as controls. Though not hypothesized, the data and design will allow for examination of this possibility. One potential conclusion from these projects could be that FM arises from an inability to enter a recovery period within which PMC could adapt and increase resilience. The proposal will be able to address at least some of the potential for this inability to recover.

Enrollment

180 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Asymptomatic people (ie no current pain conditions)
  • Participants with widespread muscle pain (WMP) aged 18 years of age and older
  • Participants with WMP must meet the ACR (2010) diagnostic criteria of multiple regions of muscle pain
  • The asymptomatic group will be free of current wrist/hand, elbow, or shoulder pain and chronic pain conditions (eg irritable bowel syndrome, FM)

Exclusion criteria

  1. Participation in a conditioning program specific to the biceps in the past 6 months
  2. Any report of wrist/hand, elbow, or shoulder pain in the last 3 months
  3. Any chronic medical conditions that may affect pain perception (e.g., diabetes, high blood pressure), kidney dysfunction, muscle damage, or major psychiatric disorder
  4. Use of any intervention (including but not limited to medication, massage, and stretching) for symptoms induced by pain training for the duration of the study
  5. Positive result on pre-MRI metal screening or pregnancy test due to contraindication for the MRI environment.
  6. Any participant with ferromagnetic metal in the head, neck, or abdominal cavity

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

180 participants in 3 patient groups

Repeated exposure
Active Comparator group
Description:
Participants will complete four exercise sessions designed to induce delayed onset muscle soreness in the biceps
Treatment:
Behavioral: Delayed onset muscle soreness.
Single exposure
Active Comparator group
Description:
Participants will complete one exercise session designed to induce delayed onset muscle soreness
Treatment:
Behavioral: Delayed onset muscle soreness.
Natural history
No Intervention group
Description:
Participants will complete all sensory testing and imaging but not perform any exercise sessions.

Trial contacts and locations

1

Loading...

Central trial contact

Mark D Bishop, PhD; Jeff Boissoneault, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems